Moving medicine from reactive treatment to proactive mastery.

The VitalScan ANS+ System by US MedResources is an FDA-cleared, non-invasive diagnostic platform that performs comprehensive autonomic nervous system (ANS), cardiovascular, and vascular function assessments in approximately 15 minutes. With a 30-year clinical track record, VitalScan helps medical practices detect autonomic and vascular dysfunction earlier — before symptoms escalate into costly complications like diabetic neuropathy, peripheral arterial disease, or sudden cardiac events.

VitalScan is built for medical practices that want to add in-office diagnostic revenue while improving patient outcomes. It serves independent and group practices across cardiology, neurology, endocrinology, podiatry, pain medicine, primary care, internal medicine, and pulmonology — specialties that manage patient populations with diabetes, cardiovascular disease, neuropathy, and peripheral vascular conditions. Each test is billable under established CPT codes (95921–95924, 93922–93971), covered by most major insurers, and can generate significant monthly revenue for practices that integrate routine autonomic and vascular screening into their standard of care.

US MedResources builds and supports the VitalScan ANS+ System, offering practices a complete package: the diagnostic hardware, clinical training, CPT billing guidance, financing options, Section 179 tax deduction resources, and grant assistance. Our mission is to equip clinicians with the tools they need to move from reactive treatment to proactive, data-driven care — catching disease earlier, improving patient quality of life, and creating sustainable practice revenue through in-office diagnostics.